ANG II receptor blockade enhances anti-inflammatory macrophages in anti-glomerular basement membrane glomerulonephritis (Q43195252)

15 November 2017

ANG II receptor blockade enhances anti-inflammatory macrophages in anti-glomerular basement membrane glomerulonephritis (English)

1 reference

15 November 2017

0 references

1 reference

2

Akira Shimizu

1 reference

15 November 2017

Kaoru Aki

1

1 reference

15 November 2017

Yukinari Masuda

3

1 reference

15 November 2017

Naomi Kuwahara

4

1 reference

15 November 2017

Takashi Arai

5

1 reference

15 November 2017

Arimi Ishikawa

6

1 reference

15 November 2017

Emiko Fujita

7

1 reference

15 November 2017

Akiko Mii

8

1 reference

15 November 2017

Yasuhiro Natori

9

1 reference

15 November 2017

Yoshitaka Fukunaga

10

1 reference

15 November 2017

Yuh Fukuda

11

1 reference

15 November 2017

13 January 2010

1 reference

American Journal of Physiology - Renal Physiology

15 November 2017

1 reference

15 November 2017

298

1 reference

15 November 2017

4

1 reference

15 November 2017

F870-82

1 reference

PPARγ Activation Primes Human Monocytes into Alternative M2 Macrophages with Anti-inflammatory Properties

15 November 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

Angiotensin II receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

Activation of a local tissue angiotensin system in podocytes by mechanical strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

Molecular activation of PPARgamma by angiotensin II type 1-receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

Macrophages in renal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

Inflammatory cells in renal injury and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

Alternative activation of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

Progression of renal disease: renoprotective specificity of renin-angiotensin system blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

Suppression of PLCbeta2 by endotoxin plays a role in the adenosine A(2A) receptor-mediated switch of macrophages from an inflammatory to an angiogenic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

Effects of therapeutic agents on the inflammatory and fibrogenic factors in IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

The sialoadhesin (CD169) expressing a macrophage subset in human proliferative glomerulonephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

Multiple facets of macrophages in renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

The chemokine system in diverse forms of macrophage activation and polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

Macrophage activation and polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

Angiotensin II receptor blockade inhibits acute glomerular injuries with the alteration of receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

Induction of human adiponectin gene transcription by telmisartan, angiotensin receptor blocker, independently on PPAR-gamma activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

The many faces of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

Exploring the full spectrum of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

Peritubular capillary regression during the progression of experimental obstructive nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

Upregulation of renin-angiotensin system during differentiation of monocytes to macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

Macrophage diversity in renal injury and repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

Proinflammatory actions of angiotensins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

Renin-angiotensin-aldosterone system and progression of renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

Angiotensin II-induced reactive oxygen species and the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

Mechanisms for the clinical benefits of angiotensin II receptor blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

Telmisartan increases fatty acid oxidation in skeletal muscle through a peroxisome proliferator-activated receptor-gamma dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

Inflammation and angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

Telmisartan inhibits CD4-positive lymphocyte migration independent of the angiotensin type 1 receptor via peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

Potential utility of telmisartan, an angiotensin II type 1 receptor blocker with peroxisome proliferator-activated receptor-gamma (PPAR-gamma)-modulating activity for the treatment of cardiometabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00374.2009

10.1152/AJPRENAL.00374.2009

21 January 2018

Identifiers

DOI

1 reference

15 November 2017

1 reference